1,550 research outputs found

    Anomalous size dependent rheological behavior of alumina based nanofluids

    Get PDF
    This paper was presented at the 2nd Micro and Nano Flows Conference (MNF2009), which was held at Brunel University, West London, UK. The conference was organised by Brunel University and supported by the Institution of Mechanical Engineers, IPEM, the Italian Union of Thermofluid dynamics, the Process Intensification Network, HEXAG - the Heat Exchange Action Group and the Institute of Mathematics and its Applications.Rheological behaviour of Alumina (Al2O3) based nanofluids (NFs) has been studied and found to be exhibit unexpected behaviour. Two base-fluids viz, water and ethylene glycols (EG). Three particle sizes (11, 45 and 150 nm), varying over an order of magnitude, were used to analyze the effect of particle size. The experimental data has shown typical Newtonian behavior for both W based and EG based alumina NFs The viscosity of EG based NFs is found to be anomalously reduced compared to the base fluid. This reduction in viscosity may be due to hygroscopic nature of EG or due to the presence of water in as-received high concentration sample also, as told by some researchers. However, this phenomenon was absent for water based NFs. The inter-related effects of particle size, concentration and mode of dispersion (mono or poly-dispersed) were investigated. To eliminate the effect of size variation, mono dispersed NFs are obtained by centrifuging and re-suspension of parent NFs. Particle migration under shear is attributed to the reduction of viscosity. The increase in bulk viscosity with particle size reduction is attributed to the surface forces acting between the particles and the medium in a suspension

    COMBINING ABILITY ANALYSIS FOR GREEN FRUIT YIELD AND ITS COMPONENT TRAITS IN CHILLI (Capsicum annuum L.)

    Get PDF
    ABSTRACTObjectives: Chilli is classified under self pollinated crops, natural cross pollination takes place up to the extent of 7 to 60 %.   Present study of combining ability analysis was conducted for identifying the superior parents for obtaining superior hybrid combinations in Chilli using male sterile lines.Methods: The present study was conducted at of Main Vegetable Research Station, Anand Agricultural University, Anand (Gujarat) during Kharif-Rabi 2011-2012 season with the objective of getting information on combining ability and nature of gene action for fruit yield and its component characters in chilli.Results: Parents viz., ACMS 4, 9907-9611 (B line), LCA 206, ACG 12 and RHRC PENDT were good general combiner for green fruit yield per plant and its related attributes.Conclusion: The estimates of specific combining ability effect indicated that cross combinations ACMS-4 x 9955-15R, CCA-4759 x LCA 206 and ACMS-8 x RHRC PENDT were significant for green fruit yield per plant and its important component characters and, therefore, these can be further exploited for selection of hybrids and transgressive segregants

    Discovery of a maximum damage structure for Xe-irradiated borosilicate glass ceramics containing powellite

    Get PDF
    In order to increase the waste loading efficiency in nuclear waste glasses, alternate glass ceramic (GC) materials are sought that trap problematic molybdenum in a water-durable CaMoO4 phase within a borosilicate glass matrix. In order to test the radiation resistance of these candidate wasteforms, accelerated external radiation can be employed to replicate long-term damage. In this study, several glasses and GCs were synthesized with up to 10 mol% MoO3 and subjected to 92 MeV Xe ions with fluences ranging between 5 × 10^12 to 1.8 × 10^14 ions/cm2. The main mechanisms of modification following irradiation involve: (i) thermal and defect-assisted diffusion, (ii) relaxation from the ion's added energy, (iii) localized damage recovery from overlapping ion tracks, and (iv) the accumulation of point defects or the formation of voids that created significant strain and led to longer-range modifications. Most significantly, a saturation in alteration could be detected for fluences greater than 4 × 10^13 ions/cm2, which represents an average structure that is representative of the maximum damage state from these competing mechanisms. The results from this study can therefore be used for long-term structural projections in the development of more complex GCs for nuclear waste applications.EPSRC (Grant No. EP/K007882/1

    Skp is a multivalent chaperone of outer membrane proteins

    Get PDF
    The trimeric chaperone Skp sequesters outer-membrane proteins (OMPs) within a hydrophobic cage, thereby preventing their aggregation during transport across the periplasm in Gram-negative bacteria. Here, we studied the interaction between Escherichia coli Skp and five OMPs of varying size. Investigations of the kinetics of OMP folding revealed that higher Skp/OMP ratios are required to prevent the folding of 16-stranded OMPs compared with their 8-stranded counterparts. Ion mobility spectrometry–mass spectrometry (IMS–MS) data, computer modeling and molecular dynamics simulations provided evidence that 10- to 16-stranded OMPs are encapsulated within an expanded Skp substrate cage. For OMPs that cannot be fully accommodated in the expanded cavity, sequestration is achieved by binding of an additional Skp trimer. The results suggest a new mechanism for Skp chaperone activity involving the coordination of multiple copies of Skp in protecting a single substrate from aggregation

    Characterizing the morbid genome of ciliopathies

    Get PDF
    Background Ciliopathies are clinically diverse disorders of the primary cilium. Remarkable progress has been made in understanding the molecular basis of these genetically heterogeneous conditions; however, our knowledge of their morbid genome, pleiotropy, and variable expressivity remains incomplete. Results We applied genomic approaches on a large patient cohort of 371 affected individuals from 265 families, with phenotypes that span the entire ciliopathy spectrum. Likely causal mutations in previously described ciliopathy genes were identified in 85% (225/265) of the families, adding 32 novel alleles. Consistent with a fully penetrant model for these genes, we found no significant difference in their “mutation load” beyond the causal variants between our ciliopathy cohort and a control non-ciliopathy cohort. Genomic analysis of our cohort further identified mutations in a novel morbid gene TXNDC15, encoding a thiol isomerase, based on independent loss of function mutations in individuals with a consistent ciliopathy phenotype (Meckel-Gruber syndrome) and a functional effect of its deficiency on ciliary signaling. Our study also highlighted seven novel candidate genes (TRAPPC3, EXOC3L2, FAM98C, C17orf61, LRRCC1, NEK4, and CELSR2) some of which have established links to ciliogenesis. Finally, we show that the morbid genome of ciliopathies encompasses many founder mutations, the combined carrier frequency of which accounts for a high disease burden in the study population. Conclusions Our study increases our understanding of the morbid genome of ciliopathies. We also provide the strongest evidence, to date, in support of the classical Mendelian inheritance of Bardet-Biedl syndrome and other ciliopathies

    Epigenetic polypharmacology: from combination therapy to multitargeted drugs

    Get PDF
    The modern drug discovery process has largely focused its attention in the so-called magic bullets, single chemical entities that exhibit high selectivity and potency for a particular target. This approach was based on the assumption that the deregulation of a protein was causally linked to a disease state, and the pharmacological intervention through inhibition of the deregulated target was able to restore normal cell function. However, the use of cocktails or multicomponent drugs to address several targets simultaneously is also popular to treat multifactorial diseases such as cancer and neurological disorders. We review the state of the art with such combinations that have an epigenetic target as one of their mechanisms of action. Epigenetic drug discovery is a rapidly advancing field, and drugs targeting epigenetic enzymes are in the clinic for the treatment of hematological cancers. Approved and experimental epigenetic drugs are undergoing clinical trials in combination with other therapeutic agents via fused or linked pharmacophores in order to benefit from synergistic effects of polypharmacology. In addition, ligands are being discovered which, as single chemical entities, are able to modulate multiple epigenetic targets simultaneously (multitarget epigenetic drugs). These multiple ligands should in principle have a lower risk of drug-drug interactions and drug resistance compared to cocktails or multicomponent drugs. This new generation may rival the so-called magic bullets in the treatment of diseases that arise as a consequence of the deregulation of multiple signaling pathways provided the challenge of optimization of the activities shown by the pharmacophores with the different targets is addressed

    Collaborative care for depression and anxiety problems

    Get PDF
    This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2012, Issue 10. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.Common mental health problems, such as depression and anxiety, are estimated to affect up to 15% of the UK population at any one time, and health care systems worldwide need to implement interventions to reduce the impact and burden of these conditions. Collaborative care is a complex intervention based on chronic disease management models that may be effective in the management of these common mental health problems

    Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017

    Get PDF
    Background Understanding the patterns of HIV/AIDS epidemics is crucial to tracking and monitoring the progress of prevention and control efforts in countries. We provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980–2017 and forecast these estimates to 2030 for 195 countries and territories. Methods We determined a modelling strategy for each country on the basis of the availability and quality of data. For countries and territories with data from population-based seroprevalence surveys or antenatal care clinics, we estimated prevalence and incidence using an open-source version of the Estimation and Projection Package—a natural history model originally developed by the UNAIDS Reference Group on Estimates, Modelling, and Projections. For countries with cause-specific vital registration data, we corrected data for garbage coding (ie, deaths coded to an intermediate, immediate, or poorly defined cause) and HIV misclassification. We developed a process of cohort incidence bias adjustment to use information on survival and deaths recorded in vital registration to back-calculate HIV incidence. For countries without any representative data on HIV, we produced incidence estimates by pulling information from observed bias in the geographical region. We used a re-coded version of the Spectrum model (a cohort component model that uses rates of disease progression and HIV mortality on and off ART) to produce age-sex-specific incidence, prevalence, and mortality, and treatment coverage results for all countries, and forecast these measures to 2030 using Spectrum with inputs that were extended on the basis of past trends in treatment scale-up and new infections. Findings Global HIV mortality peaked in 2006 with 1·95 million deaths (95% uncertainty interval 1·87–2·04) and has since decreased to 0·95 million deaths (0·91–1·01) in 2017. New cases of HIV globally peaked in 1999 (3·16 million, 2·79–3·67) and since then have gradually decreased to 1·94 million (1·63–2·29) in 2017. These trends, along with ART scale-up, have globally resulted in increased prevalence, with 36·8 million (34·8–39·2) people living with HIV in 2017. Prevalence of HIV was highest in southern sub-Saharan Africa in 2017, and countries in the region had ART coverage ranging from 65·7% in Lesotho to 85·7% in eSwatini. Our forecasts showed that 54 countries will meet the UNAIDS target of 81% ART coverage by 2020 and 12 countries are on track to meet 90% ART coverage by 2030. Forecasted results estimate that few countries will meet the UNAIDS 2020 and 2030 mortality and incidence targets. Interpretation Despite progress in reducing HIV-related mortality over the past decade, slow decreases in incidence, combined with the current context of stagnated funding for related interventions, mean that many countries are not on track to reach the 2020 and 2030 global targets for reduction in incidence and mortality. With a growing population of people living with HIV, it will continue to be a major threat to public health for years to come. The pace of progress needs to be hastened by continuing to expand access to ART and increasing investments in proven HIV prevention initiatives that can be scaled up to have population-level impact
    corecore